Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies.

about

Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies.

Item

http://www.wikidata.org/entity/Q49906338

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies.

@en

Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies.

@nl

type

Item

label

Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies.

@en

Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies.

@nl

prefLabel

Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies.

@en

Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies.

@nl

P1476

Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies.

@en

P2093

Amy Pruitt

http://www.w3.org/2001/XMLSchema#string

Elena Grebenciucova

http://www.w3.org/2001/XMLSchema#string

P2860

The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.

The mechanism of action of interferon-β in relapsing multiple sclerosis

Type I interferons in infectious disease

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

Interferons and their actions

Natalizumab-associated PML: Challenges with incidence, resulting risk, and risk stratification.

Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions.

Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.

P2888

s11910-017-0800-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11910-017-0800-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091897574

http://www.w3.org/2001/XMLSchema#string

P698

28940162

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis